Enocitabine
Enocitabine
Enocitabine (pronunciation: /ɛnəˈsɪtəbiːn/) is a nucleoside analogue used in the treatment of various types of cancer. It is a synthetic compound that mimics the structure of natural nucleosides, the building blocks of DNA and RNA.
Etymology
The term "Enocitabine" is derived from the Greek words "enos" meaning "one" and "cytos" meaning "cell". The suffix "-bine" is commonly used in the names of nucleoside analogues.
Mechanism of Action
Enocitabine works by incorporating itself into the DNA of cancer cells, thereby disrupting their ability to replicate and ultimately leading to cell death. This is achieved through its ability to inhibit the enzyme DNA polymerase, which is essential for DNA replication.
Related Terms
Side Effects
Like all chemotherapy drugs, Enocitabine can have side effects. These may include nausea, vomiting, hair loss, and fatigue. More serious side effects can include bone marrow suppression, leading to a decrease in white blood cells, red blood cells, and platelets.
See Also
External links
- Medical encyclopedia article on Enocitabine
- Wikipedia's article - Enocitabine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski